Nagpur
08048073361
+918788624929
Anti Diabetic Injection

Semasize 0.25 mg - Semaglutide solution for injection 2mg/1.5ml (1.34mg/ml)

In stockcod not available
Phone Number

08048073361

Please keep 0 before dialling the number.

Email Address lumenimpex@gmail.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Somwaripeth , Nagpur , Nagpur

Nagpur, India, 440024

Description

Semasize 0.25 mg is a prescription medication containing Semaglutide (1.34 mg/ml in a 2 mg/1.5 ml multi-dose pen), primarily used as an initiation dose to manage Type 2 Diabetes Mellitus and support long-term weight management. This specific 0.25 mg strength is a starting dose meant to help your body adapt to the medicine and minimize digestive side effects before you step up to higher therapeutic doses. It belongs to a class of drugs known as GLP-1 receptor agonists.

Keywords

Other Products

view all

Card 2

product image
Anti Diabetic Injection

Semasize 0.25 mg is a prescription medication containing Semaglutide (1.34 mg/ml in a 2 mg/1.5 ml multi-dose pen), primarily used as an initiation dose to manage Type 2 Diabetes Mellitus and support long-term weight management. This specific 0.25 mg strength is a starting dose meant to help your body adapt to the medicine and minimize digestive side effects before you step up to higher therapeutic doses. It belongs to a class of drugs known as GLP-1 receptor agonists.

Card 2

product image
Veterinary medicine

Octinib 5.4 mg is a prescription veterinary medication containing Oclacitinib Maleate, primarily used to control severe itching (pruritus) and skin inflammation in dogs. It acts as a selective Janus kinase (JAK) inhibitor, targeting and blocking the specific chemical pathways (cytokines) that trigger allergic itch and inflammation.

Card 2

product image
Antidiabetic and Anti-obesity medication

Semasize Plus 1.7 mg is a prescription medication containing semaglutide, primarily used for chronic weight management, glycemic control in type 2 diabetes, and reducing cardiovascular risk.